R v Kerollos

In the matter of R v Kerollos, the defendant was charged with the murder of a person in Victoria. The case was heard in the Supreme Court of Victoria. The defendant's legal representatives sought a trial by judge alone, citing concerns about the defendant's mental health and the impact of the COVID-19 pandemic on the proceedings. The prosecution opposed the application, arguing that the defendant's mental health issues were not sufficient grounds for a trial by judge alone and that the pandemic delays should not be a mitigating factor.

The court was required to consider whether the defendant's mental health issues and the substantial impairment they caused were sufficient grounds for a trial by judge alone. Additionally, the court had to determine whether the credibility of witnesses was a neutral issue and whether the mitigating factor of coronavirus delays was significant enough to warrant a trial by judge alone in the interests of justice. The court considered the evidence presented by both parties, including expert medical opinions on the defendant's mental health and the impact of the COVID-19 pandemic on the proceedings.

The court found that the defendant's mental health issues and substantial impairment did not make the credibility of witnesses a neutral issue, as the defendant's mental state could potentially affect their ability to perceive and recall events accurately. However, the court also acknowledged that the COVID-19 pandemic had caused significant delays in the proceedings, which could impact the defendant's right to a fair trial. The court concluded that the mitigating factor of coronavirus delays was significant enough to warrant a trial by judge alone in the interests of justice. The application for a trial by judge alone was granted.

The final orders of the court were that the matter would proceed to trial by a judge alone, taking into account the mitigating factor of coronavirus delays and the defendant's mental health issues. The court also directed the parties to make further submissions on the appropriate date for the trial, considering the ongoing impact of the COVID-19 pandemic.